JP5225844B2 - 半月板断裂を修復するためのコラーゲン膜材料のシート - Google Patents
半月板断裂を修復するためのコラーゲン膜材料のシート Download PDFInfo
- Publication number
- JP5225844B2 JP5225844B2 JP2008529334A JP2008529334A JP5225844B2 JP 5225844 B2 JP5225844 B2 JP 5225844B2 JP 2008529334 A JP2008529334 A JP 2008529334A JP 2008529334 A JP2008529334 A JP 2008529334A JP 5225844 B2 JP5225844 B2 JP 5225844B2
- Authority
- JP
- Japan
- Prior art keywords
- sheet
- membrane material
- collagen
- collagen membrane
- material according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000012528 membrane Substances 0.000 title claims description 69
- 102000008186 Collagen Human genes 0.000 title claims description 54
- 108010035532 Collagen Proteins 0.000 title claims description 54
- 229920001436 collagen Polymers 0.000 title claims description 54
- 239000000463 material Substances 0.000 title claims description 50
- 230000008439 repair process Effects 0.000 title claims description 14
- 210000004379 membrane Anatomy 0.000 claims description 68
- 102000012422 Collagen Type I Human genes 0.000 claims description 17
- 108010022452 Collagen Type I Proteins 0.000 claims description 17
- 239000000835 fiber Substances 0.000 claims description 15
- 210000002437 synoviocyte Anatomy 0.000 claims description 13
- 210000004027 cell Anatomy 0.000 claims description 12
- 230000004888 barrier function Effects 0.000 claims description 11
- 210000005222 synovial tissue Anatomy 0.000 claims description 9
- 241000283690 Bos taurus Species 0.000 claims description 8
- 210000004303 peritoneum Anatomy 0.000 claims description 5
- 108010049931 Bone Morphogenetic Protein 2 Proteins 0.000 claims description 4
- 102100024506 Bone morphogenetic protein 2 Human genes 0.000 claims description 4
- 229920002683 Glycosaminoglycan Polymers 0.000 claims description 4
- 239000000853 adhesive Substances 0.000 claims description 4
- 230000001070 adhesive effect Effects 0.000 claims description 4
- 230000021164 cell adhesion Effects 0.000 claims description 4
- 230000010261 cell growth Effects 0.000 claims description 4
- 239000003102 growth factor Substances 0.000 claims description 4
- 108010049870 Bone Morphogenetic Protein 7 Proteins 0.000 claims description 3
- 102100022544 Bone morphogenetic protein 7 Human genes 0.000 claims description 3
- 108010080379 Fibrin Tissue Adhesive Proteins 0.000 claims description 3
- 101000599951 Homo sapiens Insulin-like growth factor I Proteins 0.000 claims description 3
- 102100037852 Insulin-like growth factor I Human genes 0.000 claims description 3
- 102000004887 Transforming Growth Factor beta Human genes 0.000 claims description 3
- 108090001012 Transforming Growth Factor beta Proteins 0.000 claims description 3
- ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical group C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 claims description 3
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims description 2
- 229920001287 Chondroitin sulfate Polymers 0.000 claims description 2
- 102000001187 Collagen Type III Human genes 0.000 claims description 2
- 108010069502 Collagen Type III Proteins 0.000 claims description 2
- 229920000045 Dermatan sulfate Polymers 0.000 claims description 2
- 102000011782 Keratins Human genes 0.000 claims description 2
- 108010076876 Keratins Proteins 0.000 claims description 2
- 206010072970 Meniscus injury Diseases 0.000 claims description 2
- 102000010780 Platelet-Derived Growth Factor Human genes 0.000 claims description 2
- 108010038512 Platelet-Derived Growth Factor Proteins 0.000 claims description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 claims description 2
- 210000001612 chondrocyte Anatomy 0.000 claims description 2
- AVJBPWGFOQAPRH-FWMKGIEWSA-L dermatan sulfate Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@H](OS([O-])(=O)=O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](C([O-])=O)O1 AVJBPWGFOQAPRH-FWMKGIEWSA-L 0.000 claims description 2
- 229940051593 dermatan sulfate Drugs 0.000 claims description 2
- 229920002674 hyaluronan Polymers 0.000 claims description 2
- 229960003160 hyaluronic acid Drugs 0.000 claims description 2
- 210000002901 mesenchymal stem cell Anatomy 0.000 claims description 2
- 210000001179 synovial fluid Anatomy 0.000 claims description 2
- VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 claims description 2
- 239000000203 mixture Substances 0.000 claims 2
- 102000009024 Epidermal Growth Factor Human genes 0.000 claims 1
- 101800003838 Epidermal growth factor Proteins 0.000 claims 1
- 102000003745 Hepatocyte Growth Factor Human genes 0.000 claims 1
- 108090000100 Hepatocyte Growth Factor Proteins 0.000 claims 1
- 229940116977 epidermal growth factor Drugs 0.000 claims 1
- 230000005499 meniscus Effects 0.000 description 12
- 238000000034 method Methods 0.000 description 4
- 210000002808 connective tissue Anatomy 0.000 description 3
- 230000035876 healing Effects 0.000 description 3
- 241000282887 Suidae Species 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 210000001258 synovial membrane Anatomy 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 102100032528 C-type lectin domain family 11 member A Human genes 0.000 description 1
- 101710167766 C-type lectin domain family 11 member A Proteins 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 230000006820 DNA synthesis Effects 0.000 description 1
- 238000012404 In vitro experiment Methods 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 238000004026 adhesive bonding Methods 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 231100000673 dose–response relationship Toxicity 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 238000010562 histological examination Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 108010000685 platelet-derived growth factor AB Proteins 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
- A61L27/24—Collagen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/005—Ingredients of undetermined constitution or reaction products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/04—Macromolecular materials
- A61L31/043—Proteins; Polypeptides; Degradation products thereof
- A61L31/044—Collagen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/06—Materials or treatment for tissue regeneration for cartilage reconstruction, e.g. meniscus
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S623/00—Prosthesis, i.e. artificial body members, parts thereof, or aids and accessories therefor
- Y10S623/902—Method of implanting
- Y10S623/908—Bone
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Surgery (AREA)
- Transplantation (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Dermatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- Zoology (AREA)
- Botany (AREA)
- Biophysics (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Immunology (AREA)
- Materials For Medical Uses (AREA)
- Prostheses (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US71336005P | 2005-09-02 | 2005-09-02 | |
| US60/713,360 | 2005-09-02 | ||
| PCT/US2006/034329 WO2007028078A2 (en) | 2005-09-02 | 2006-09-01 | Method of repairing meniscal tears |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012201621A Division JP2012236112A (ja) | 2005-09-02 | 2012-09-13 | 半月板断裂を修復するためのコラーゲン膜材料のシート |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2009506841A JP2009506841A (ja) | 2009-02-19 |
| JP2009506841A5 JP2009506841A5 (cg-RX-API-DMAC10.html) | 2009-10-22 |
| JP5225844B2 true JP5225844B2 (ja) | 2013-07-03 |
Family
ID=37809610
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008529334A Expired - Fee Related JP5225844B2 (ja) | 2005-09-02 | 2006-09-01 | 半月板断裂を修復するためのコラーゲン膜材料のシート |
| JP2012201621A Withdrawn JP2012236112A (ja) | 2005-09-02 | 2012-09-13 | 半月板断裂を修復するためのコラーゲン膜材料のシート |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012201621A Withdrawn JP2012236112A (ja) | 2005-09-02 | 2012-09-13 | 半月板断裂を修復するためのコラーゲン膜材料のシート |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US8084428B2 (cg-RX-API-DMAC10.html) |
| EP (1) | EP1937293B1 (cg-RX-API-DMAC10.html) |
| JP (2) | JP5225844B2 (cg-RX-API-DMAC10.html) |
| CN (1) | CN101252948A (cg-RX-API-DMAC10.html) |
| AU (1) | AU2006287197B2 (cg-RX-API-DMAC10.html) |
| CA (1) | CA2621153C (cg-RX-API-DMAC10.html) |
| ES (1) | ES2439943T3 (cg-RX-API-DMAC10.html) |
| PL (1) | PL1937293T3 (cg-RX-API-DMAC10.html) |
| RU (1) | RU2421173C2 (cg-RX-API-DMAC10.html) |
| WO (1) | WO2007028078A2 (cg-RX-API-DMAC10.html) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5154427B2 (ja) * | 2005-10-24 | 2013-02-27 | エー・デー・ガイストリヒ・ゾーネ・アクチェンゲゼルシャフト・フュール・ヒェーミシェ・インダストリー | 滑膜細胞が充填されるコラーゲン膜またはゲルのための方法および装置 |
| EP2148887B1 (en) | 2007-04-19 | 2014-04-30 | Fibralign Corporation | Oriented collagen-based materials, films and methods of making same |
| US8513382B2 (en) | 2008-08-11 | 2013-08-20 | Fibralign Corporation | Biocomposites and methods of making the same |
| US10086079B2 (en) | 2008-08-11 | 2018-10-02 | Fibralign Corporation | Biocomposites and methods of making the same |
| CN101756503A (zh) * | 2008-11-07 | 2010-06-30 | 南通芯迎设计服务有限公司 | 一种多功能桌子 |
| RU2551009C2 (ru) | 2009-01-16 | 2015-05-20 | Гайстлих Фарма Аг | Способ и мембрана для регенерации кожи |
| US10806833B1 (en) | 2009-05-11 | 2020-10-20 | Integra Lifesciences Corporation | Adherent resorbable matrix |
| US20110059178A1 (en) * | 2009-09-08 | 2011-03-10 | Musculoskeletal Transplant Foundation Inc. | Tissue Engineered Meniscus Repair Composition |
| WO2011031642A2 (en) * | 2009-09-08 | 2011-03-17 | Musculoskeletal Transplant Foundation Inc. | Tissue engineered meniscus repair composition |
| US10065046B2 (en) | 2010-07-15 | 2018-09-04 | Fibralign Corporation | Conductive biopolymer implant for enhancing tissue repair and regeneration using electromagnetic fields |
| EP2613818B1 (en) | 2010-09-10 | 2019-02-13 | Fibralign Corp. | Biodegradable multilayer constructs |
| CN102229647B (zh) * | 2011-06-09 | 2013-02-20 | 北京大学第三医院 | 滑膜间充质干细胞亲和多肽修饰植入人体支架的方法 |
| WO2013103423A2 (en) | 2011-10-11 | 2013-07-11 | Fibralign Corporation | A graft for directed vascular and lymphatic regeneration and methods to guide endothelial cell assembly |
| CN102716515B (zh) * | 2012-07-02 | 2014-01-29 | 陕西博鸿生物科技有限公司 | 一种修复半月板撕裂的生物材料及其制备方法 |
| EP2900808B1 (en) | 2012-09-28 | 2019-04-03 | Scripps Health | Methods of differentiating stem cells into chondrocytes |
| WO2015054654A1 (en) | 2013-10-10 | 2015-04-16 | Fibralign Corporation | Method and device for lymphedema treatment |
| CN105903079A (zh) * | 2016-05-20 | 2016-08-31 | 中国人民解放军总医院 | 半月板基质来源的三维多孔海绵状支架、制备方法及应用 |
| WO2019113558A1 (en) * | 2017-12-07 | 2019-06-13 | Vericel Corporation | Compositions and methods for repairing cartilage defects |
| KR102684366B1 (ko) | 2018-10-05 | 2024-07-11 | 고쿠리츠다이가쿠호진 히로시마다이가쿠 | 반월판 재생용 재료 |
| JP7546061B2 (ja) | 2020-02-11 | 2024-09-05 | エンボディ，インコーポレイテッド | インプラント送達装置 |
| JP2023514193A (ja) | 2020-02-11 | 2023-04-05 | エンボディ，インコーポレイテッド | 取り外し可能な圧力シール付き外科用カニューレ |
| CN115484875A (zh) | 2020-02-11 | 2022-12-16 | 恩博迪股份有限公司 | 外科锚固装置、部署装置及使用方法 |
| PL247461B1 (pl) | 2020-10-14 | 2025-07-07 | Chyla Marcin | Kolagenowa kapa łąkotkowa i sposób wytwarzania kolagenowej kapy łąkotkowej |
| RU2761965C1 (ru) * | 2020-11-23 | 2021-12-14 | Александр Олегович Тутуров | Способ артроскопической рефиксации разрывов менисков при сочетанном повреждении связок коленного сустава |
| JP7652382B2 (ja) * | 2020-12-16 | 2025-03-27 | 学校法人大阪医科薬科大学 | 半月板再生基材 |
| US12582749B2 (en) | 2021-01-04 | 2026-03-24 | Vivex Biologics Group, Inc. | Meniscus tear repair sling device |
| EP4775181A2 (en) | 2022-03-04 | 2026-07-15 | Vericel Corporation | Devices for repairing cartilage defects |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5206023A (en) * | 1991-01-31 | 1993-04-27 | Robert F. Shaw | Method and compositions for the treatment and repair of defects or lesions in cartilage |
| GB9400163D0 (en) * | 1994-01-06 | 1994-03-02 | Geistlich Soehne Ag | Membrane |
| US20030039695A1 (en) * | 2001-08-10 | 2003-02-27 | Ed. Geistlich Soehne Ag Fuer Chemische Industrie | Collagen carrier of therapeutic genetic material, and method |
| US6352558B1 (en) | 1996-02-22 | 2002-03-05 | Ed. Geistlich Soehne Ag Fuer Chemische Industrie | Method for promoting regeneration of surface cartilage in a damage joint |
| DE69714035T2 (de) * | 1997-08-14 | 2003-03-06 | Sulzer Innotec Ag, Winterthur | Zusammensetzung und Vorrichtung zur Reparatur von Knorpelgewebe in vivo bestehend aus Nanokapseln mit osteoinduktiven und/oder chondroinduktiven Faktoren |
| JP2002522168A (ja) * | 1998-08-14 | 2002-07-23 | ベリゲン トランスプランタツィオーン セルビス インテルナツィオナル （フォウテーエスイー） アーゲー | 軟骨細胞移植のための方法、器具および材料 |
| US20040059416A1 (en) * | 1999-06-22 | 2004-03-25 | Murray Martha M. | Biologic replacement for fibrin clot |
| US6221109B1 (en) | 1999-09-15 | 2001-04-24 | Ed. Geistlich Söhne AG fur Chemische Industrie | Method of protecting spinal area |
| CZ301649B6 (cs) | 2000-06-28 | 2010-05-12 | Ed. Geistlich Soehne Ag Fur Chemische Industrie Incorporated Under The Laws Of Switzerland | Trubice pro regeneraci nervu a zpusob jejich výroby |
| IT1318663B1 (it) | 2000-08-02 | 2003-08-27 | Mediolanum Farmaceutici Srl | Membrane di collagene a due facce di cui una organizzata a livellomacromolecolare. |
| WO2002041930A2 (en) * | 2000-11-24 | 2002-05-30 | UNIVERSITé LAVAL | Connective tissue substitutes, method of preparation and uses thereof |
| WO2002060315A2 (en) * | 2001-01-30 | 2002-08-08 | Orthogene, Inc. | Compositions and methods for the treatment and repair of defects or lesions in articular cartilage using synovial-derived tissue or cells |
| HUP0401450A3 (en) | 2001-04-12 | 2006-11-28 | Verigen Transplantation Serv | Method for autologous transplantation |
| AU784394B2 (en) | 2001-04-27 | 2006-03-23 | Geistlich Pharma Ag | Method and membrane for mucosa regeneration |
| US6444222B1 (en) * | 2001-05-08 | 2002-09-03 | Verigen Transplantation Services International Ag | Reinforced matrices |
| JP2003160506A (ja) | 2001-08-10 | 2003-06-03 | Ed Geistlich Soehne Ag Fuer Chemische Industrie | 治療用遺伝物質のコラーゲン担体およびその方法 |
| CA2412012C (en) | 2001-11-20 | 2011-08-02 | Ed. Geistlich Soehne Ag Fuer Chemische Industrie | Resorbable extracellular matrix containing collagen i and collagen ii for reconstruction of cartilage |
| US8657881B2 (en) * | 2004-04-20 | 2014-02-25 | Depuy Mitek, Llc | Meniscal repair scaffold |
-
2006
- 2006-09-01 WO PCT/US2006/034329 patent/WO2007028078A2/en not_active Ceased
- 2006-09-01 JP JP2008529334A patent/JP5225844B2/ja not_active Expired - Fee Related
- 2006-09-01 PL PL06802853T patent/PL1937293T3/pl unknown
- 2006-09-01 RU RU2008112185/14A patent/RU2421173C2/ru active
- 2006-09-01 EP EP06802853.9A patent/EP1937293B1/en active Active
- 2006-09-01 US US12/064,444 patent/US8084428B2/en active Active
- 2006-09-01 AU AU2006287197A patent/AU2006287197B2/en not_active Ceased
- 2006-09-01 ES ES06802853.9T patent/ES2439943T3/es active Active
- 2006-09-01 CA CA2621153A patent/CA2621153C/en active Active
- 2006-09-01 CN CNA2006800316648A patent/CN101252948A/zh active Pending
-
2012
- 2012-09-13 JP JP2012201621A patent/JP2012236112A/ja not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| CA2621153C (en) | 2016-10-18 |
| RU2421173C2 (ru) | 2011-06-20 |
| WO2007028078A3 (en) | 2007-09-13 |
| US8084428B2 (en) | 2011-12-27 |
| EP1937293A4 (en) | 2011-07-20 |
| JP2012236112A (ja) | 2012-12-06 |
| WO2007028078A2 (en) | 2007-03-08 |
| EP1937293A2 (en) | 2008-07-02 |
| RU2008112185A (ru) | 2009-10-10 |
| CA2621153A1 (en) | 2007-03-08 |
| AU2006287197B2 (en) | 2013-02-14 |
| ES2439943T3 (es) | 2014-01-27 |
| EP1937293B1 (en) | 2013-11-20 |
| AU2006287197A1 (en) | 2007-03-08 |
| PL1937293T3 (pl) | 2014-03-31 |
| US20090186062A1 (en) | 2009-07-23 |
| JP2009506841A (ja) | 2009-02-19 |
| CN101252948A (zh) | 2008-08-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012236112A (ja) | 半月板断裂を修復するためのコラーゲン膜材料のシート | |
| EP2097116B1 (en) | In situ system for intra-articular chondral and osseous tissue repair | |
| US8703122B2 (en) | Method for directed cell in-growth and controlled tissue regeneration in spinal surgery | |
| US6352558B1 (en) | Method for promoting regeneration of surface cartilage in a damage joint | |
| US20070276398A1 (en) | Methods of repairing longitudinal bone defects | |
| JP2008521502A (ja) | 半月板損傷の生体内治療及び修復方法 | |
| US9017711B2 (en) | Soft tissue wrap | |
| US12064534B2 (en) | Zwitterionic hydrogels for delivery of biomolecules | |
| US11484578B2 (en) | Biomaterial for articular cartilage maintenance and treatment of arthritis | |
| KR20190127856A (ko) | 반월상연골 복원을 촉진시키기 위해 기능화 된 스캐폴드 (functionalized scaffold to promote meniscus repair) | |
| Pascual et al. | Host tissue response by the expression of collagen to cyanoacrylate adhesives used in implant fixation for abdominal hernia repair | |
| HK1128638B (en) | Collagen for use in prevention of peridural fibrosis formation after spinal surgery |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20090826 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20090826 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20090907 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20110707 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20110719 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20111013 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20120515 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20120913 |
|
| A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20120919 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20121113 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20130111 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20130219 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20130313 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 5225844 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20160322 Year of fee payment: 3 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| LAPS | Cancellation because of no payment of annual fees |